CRISPR/Cas9 technology generated a glycine to serine substitution at amino acid 210 (p.G210S). This corresponds to one of the human variants, p.G212S, identified in Gitelman syndrome. (J:336073)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count